Skip to content
Home/Companies/TMT/SynOx Therapeutics
ST

SynOx Therapeutics

TMT·Exited 2023

SynOx Therapeutics is a TMT company.

Entry
–
Hold
–
Exit
2023
Est. EV
–

Who owns SynOx Therapeutics?

SynOx Therapeutics was owned by Gimv.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

SectorTMT
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2023

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
Active
TMTBelgium
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

+44 20 3805 4822
Active
TDR CapitalUK
+44 20 7399 4200
Active
TDR CapitalUK
12.5
Active
LBO FranceFrance
1500h
Active
QUANTONATION VENTURESFrance
1stdibs
Active
Index VenturesUS
24ORE
Active
FemuQui VenturesFrance
Data refreshed weekly · Sourced from public filings